New knee implant aims for 10-Year durability in arthritis patients

NCT ID NCT07199738

First seen Jun 24, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This study is testing the LEGION Medial Stabilized knee implant in 144 people who need total knee replacement due to arthritis or joint damage. The goal is to see how well the implant holds up over 10 years without needing revision surgery. Participants will receive one of three versions of the implant, and their progress will be tracked for up to a decade.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LEGION Medial Stabilized knee implant (device)
What this could lead to
If successful, this could confirm that the LEGION knee implant is safe and durable for long-term use, helping people with arthritis or joint damage get back to daily activities.
What could go wrong
This is a mid-stage study with only 144 participants, so results may not apply to everyone. There is always a risk of implant failure, infection, or need for revision surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • New York University Hospital

    RECRUITING

    New York, New York, 10016, United States

  • Newton Wellesley Hospital

    RECRUITING

    Newton, Massachusetts, 02462, United States

  • University of Wisconsin

    NOT_YET_RECRUITING

    Madison, Wisconsin, 53715-1218, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.